Zoya Peelay

Homi Bhabha National Institute — India

Medicine · Health Sciences

7h-index382citations36works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(11), Lung Cancer Treatments and Mutations(7), Glioma Diagnosis and Treatment(5), Cancer Immunotherapy and Biomarkers(4), Colorectal Cancer Treatments and Studies(4)

Publications36 total

CAR-T in relapsed refractory high-grade glioma and glioblastoma – who, what, when and how?
ecancermedicalscience·2025Open Access
Optimizing CAR T-cell therapy for glioblastoma: AI, dose selection, and future directions
Discover Medicine·2025Open Access
Real-world evidence of toxicity profile with cellular immunotherapy from India: Cellular insights study.
Journal of Clinical Oncology·2025
PD-L1 in Oral Cavity Cancers—Audit for Tertiary Care Center in India
Indian Journal of Surgical Oncology·2025Open Access
Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory/ineligible head and neck cancer in palliative setting with survival outcomes
Cancer Letters·2025· 1 cited
Intrathecal pemetrexed in NSCLC patients with leptomeningeal metastasis
ecancermedicalscience·2024· 1 citedOpen Access
Phase III randomized trial comparing neoadjuvant paclitaxel plus platinum with 5-fluorouracil plus platinum in esophageal or gastroesophageal junction squamous cell carcinoma
JNCI Journal of the National Cancer Institute·2024· 6 cited
Under-representation of older Indian persons with cancer in clinical trials
BMJ Oncology·2024· 5 citedOpen Access
Long-Term Update of a Phase 3 Randomized Study Comparing Once-a-Week Versus Once-Every-3-Weeks Cisplatin Along With Radiation in Head and Neck Cancer
International Journal of Radiation Oncology*Biology*Physics·2024· 4 cited
Long term results of phase 3 randomized study evaluating the addition of low dose nivolumab to palliative chemotherapy in head and neck cancer.
Journal of Clinical Oncology·2024
VAMANA: A phase 2 study of low-dose bevacizumab plus CCNU in relapsed/recurrent glioblastoma.
Journal of Clinical Oncology·2024
Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Variant Lung Cancer—Long-Term Results of a Randomized Clinical Trial
JAMA Oncology·2024· 12 citedOpen Access
Underrepresentation of older Indian persons with cancer in clinical trials
Research Square (Research Square)·2024Open Access
Neoadjuvant Chemotherapy in Locally Advanced Sinonasal Teratocarcinosarcoma a Rare Malignancy: An Audit From an Academic Tertiary Care Centre in India
Clinical Oncology·2024· 1 cited
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer
European Journal of Cancer·2024· 11 cited
The Role of Systemic Therapy in Patients with Advanced Non-small Cell Lung Cancer and a Poor Eastern Cooperative Oncology Group Performance Status
Clinical Oncology·2023· 1 cited
Empty pelvis syndrome: a retrospective audit from a tertiary cancer center
Langenbeck s Archives of Surgery·2023· 7 cited
Impact of pre-treatment anemia on survival in locally advanced head neck squamous cell carcinomas treated with radiation with or without concurrent chemotherapy.
Journal of Clinical Oncology·2023
PD-L1 in head and neck cancers: Audit for tertiary care centre in India.
Journal of Clinical Oncology·2023
An audit of neoadjuvant chemotherapy in sinonasal teratocarcinosarcoma from an academic tertiary care centre in India.
Journal of Clinical Oncology·2023
page 1 of 2Next →

Frequent Co-authors

Kumar Prabhash(20), Vanita Noronha(18), Nandini Menon(18), Vijay Patil(13), Vijay Patil(12), Shruti Pathak(12), Kavita Nawale(11), Minit Shah(10), Ameya Puranik(7), Vijayalakshmi Mathrudev(6), Monica Jadhav(6), Manali Kolkur(6), Ajay Singh(5), Abhishek Mahajan(5), Shripad Banavali(5), Pankaj Chaturvedi(5), Anant Ramaswamy(5), Minit Shah(5), Deevyashali Parekh(5), Atanu Bhattacharjee(4)